Media Summary: The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ... CNBC-TV18 AIPulse AI Deals & Developments - SoftBank secures $40 Bn loan to back OpenAI - Another advancement in patient convenience indianapolis based

Eli Lilly Inks 2 8b - Detailed Analysis & Overview

The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ... CNBC-TV18 AIPulse AI Deals & Developments - SoftBank secures $40 Bn loan to back OpenAI - Another advancement in patient convenience indianapolis based The FDA has approved another obesity pill, called Foundayo, from pharmaceutical maker

Photo Gallery

Eli Lilly inks $2.8B AI drug discovery deal
SoftBank Secures $40 Billion Loan For OpenAI Investment; Eli Lilly Inks AI Drug Deal With InSilico
Eli Lilly CEO explains White House medication cost deal
Eli Lilly's Zepbound QuickPen  Easier Weight Loss Treatment
FDA approves Eli Lilly's new obesity pill
Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results
Eli Lilly stock upgraded to Buy on forecast for new diabetes drug
Eli Lilly officially announces $6.5 billion manufacturing campus in Houston
Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions
Eloralintide: Eli Lilly's Amylin Drug That Just Beat Cagrilintide and Petrelintide in Phase 2
Eli Lilly caps insulin price at $35 amid mounting political, competitive pressure
Pharmaceutical Company Eli Lilly Caps Out-of-Pocket Cost for Insulin at $35
View Detailed Profile
Eli Lilly inks $2.8B AI drug discovery deal

Eli Lilly inks $2.8B AI drug discovery deal

The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ...

SoftBank Secures $40 Billion Loan For OpenAI Investment; Eli Lilly Inks AI Drug Deal With InSilico

SoftBank Secures $40 Billion Loan For OpenAI Investment; Eli Lilly Inks AI Drug Deal With InSilico

CNBC-TV18 AIPulse | AI Deals & Developments - SoftBank secures $40 Bn loan to back OpenAI -

Eli Lilly CEO explains White House medication cost deal

Eli Lilly CEO explains White House medication cost deal

Eli Lilly

Eli Lilly's Zepbound QuickPen  Easier Weight Loss Treatment

Eli Lilly's Zepbound QuickPen Easier Weight Loss Treatment

Another advancement in patient convenience indianapolis based

FDA approves Eli Lilly's new obesity pill

FDA approves Eli Lilly's new obesity pill

The FDA has approved another obesity pill, called Foundayo, from pharmaceutical maker

Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results

Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results

CNBC's Angelica Peebles and

Eli Lilly stock upgraded to Buy on forecast for new diabetes drug

Eli Lilly stock upgraded to Buy on forecast for new diabetes drug

EliLilly

Eli Lilly officially announces $6.5 billion manufacturing campus in Houston

Eli Lilly officially announces $6.5 billion manufacturing campus in Houston

Governor Greg Abbott joined

Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions

Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions

Eli Lilly

Eloralintide: Eli Lilly's Amylin Drug That Just Beat Cagrilintide and Petrelintide in Phase 2

Eloralintide: Eli Lilly's Amylin Drug That Just Beat Cagrilintide and Petrelintide in Phase 2

Eloralintide is

Eli Lilly caps insulin price at $35 amid mounting political, competitive pressure

Eli Lilly caps insulin price at $35 amid mounting political, competitive pressure

Alex Wagner reports on drugmaker

Pharmaceutical Company Eli Lilly Caps Out-of-Pocket Cost for Insulin at $35

Pharmaceutical Company Eli Lilly Caps Out-of-Pocket Cost for Insulin at $35

Pharmaceutical company

Eli Lilly reports results from Covid-19 phase 2 antibody drug trial

Eli Lilly reports results from Covid-19 phase 2 antibody drug trial

Eli Lilly